Alpha Paradigm Partners’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-36,620
Closed -$1.35M 515
2022
Q1
$1.35M Buy
36,620
+4,357
+14% +$170K 0.53% 36
2021
Q4
$1.47M Buy
+32,263
New +$1.68M 0.59% 28

Other funds holding CDNA

Alpha Paradigm Partners's CDNA Position: Q2 2022 in Review

Alpha Paradigm Partners sold out of CareDx (CDNA) in Q2 2022, closing a stake of 36,620 shares — an estimated $1.35M sold.

Alpha Paradigm Partners first reported a position in CDNA in Q4 2021 and held it in 2 quarters. The position peaked at $1.47M in Q4 2021. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.

  • Alpha Paradigm Partners reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
  • Alpha Paradigm Partners sold 36,620 CareDx shares in Q2 2022, an estimated $1.35M.
  • Alpha Paradigm Partners first reported a position in CareDx in Q4 2021 and held it in 2 quarters.
  • Alpha Paradigm Partners's CareDx position peaked at $1.47M in Q4 2021.
  • 184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.

Based on Alpha Paradigm Partners's 13F filing for Q2 2022, filed 15 Aug 2022.